Edmonton, AB, Canada; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
London, ON, Canada; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Düsseldorf, Germany; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
München, Germany; Research Site:
A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
München, Germany; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Regensburg, Germany; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Regensburg, Germany; Research Site:
A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
Tübingen, Germany; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Jerusalem, Israel; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Milano, Italy; Research Site:
A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
Milano, Italy; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Roma, Italy; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Roma, Italy; Research Site:
A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
San Donato Milanese, Italy; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Guadalajara, Jalisco, Mexico; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Mexico City, Mexico; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Leiden, Netherlands; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Maastricht, Netherlands; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Rotterdam, Netherlands; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Kharkov, Ukraine; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Kharkov, Ukraine; Research Site:
A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
Kiev, Ukraine; Research Site:
A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
Kiev, Ukraine; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Zaporozhye, Ukraine; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Liverpool, United Kingdom; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Liverpool, United Kingdom; Research Site:
A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
Oxford, United Kingdom; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Oxford, United Kingdom; Research Site:
A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
Salford, United Kingdom; Research Site:
A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
Salford, United Kingdom; Research Site:
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
